Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemia. 1986

A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
January 1977, Oncology,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
September 1982, Cytometry,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
February 1995, Annals of hematology,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
March 1971, Cancer,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
January 1969, Minerva pediatrica,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
May 1969, Cancer,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
February 2001, Hematology/oncology clinics of North America,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
September 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
August 1976, Cancer,
A Riccardi, and R Invernizzi, and M Girino, and E Cassano, and M Giordano, and G Ucci, and M Danova, and C Montecucco, and E Bobbio-Pallavicini, and E Ascari
December 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!